Monitoring the Treatment Efficacy of the Vascular Disrupting Agent CA4P

Lignende værker

• Characterizing the Tumor Response to CA4P Treatment
  af: Salmon, Beth A., et al.
  Udgivet: (2007)
• Dual Targeting of Tumor Vasculature: Combining Avastin and Vascular Disrupting Agents (CA4P or OXi4503)
  af: Siemann, Dietmar W., et al.
  Udgivet: (2008)
• The Unique Characteristics of Tumor Vasculature and Preclinical Evidence for its Selective Disruption by Tumor-Vascular Disrupting Agents
  af: Siemann, Dietmar W.
  Udgivet: (2010)
• The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors
  af: Deng, Changwen, et al.
  Udgivet: (2020)
• A REVIEW AND UPDATE OF THE CURRENT STATUS OF THE VASCULATURE DISABLING AGENT COMBRETASTATIN-A4 PHOSPHATE (CA4P)
  af: Siemann, Dietmar W., et al.
  Udgivet: (2009)